All Health Care News
Top stories summarized by our editors
12/10/2018

Researchers recruited 525 patients with diabetes and found that fasting-evoked en route hypoglycemia events were more likely to happen among those who fasted before a blood cholesterol test and could lead to life-threatening accidents. The findings in the International Journal of Endocrinology revealed that "FEEHD is overlooked in clinical practice, and we aim to bring this problem to light and further educate doctors and patients about the consequences of fasting while on diabetes medications," said study author Saleh Aldasouqi.

Full Story:
Medical News Today
More Summaries:
diabetes
12/10/2018

A study in the Journal of Diabetes showed that patients with peripheral artery disease and diabetes diagnosis based on A1C levels had a higher all-cause mortality risk after undergoing vascular surgery than those with normal A1C levels. Norwegian researchers evaluated 273 patients with unknown glycemic status and found a 79% rate of all-cause mortality among those with diagnosed diabetes.

12/10/2018

Minneapolis-based Carrot Health was one of the health care startups using emerging digital tools that were featured at the 11th annual Executive Conference on the Future of Health Care. Carrot created a model, using data from millions of people, that predicts individual health care usage, which health systems use to find patients who might benefit from case management and lifestyle counseling.

More Summaries:
Carrot
12/10/2018

Gilead Sciences on Monday named Daniel O'Day its new CEO as the drug company seeks to revive revenues hard hit by decreasing sales of its blockbuster hepatitis C drugs. O'Day, who has a history of developing drugs that become big sellers, will be tasked to ensure the success of the CAR T-cell cancer treatment Yescarta, which has lagged in sales.

More Summaries:
Daniel O'Day, Gilead Sciences
12/10/2018

A HealthDay/Harris Poll found 71% of US adults were not familiar with personalized medicine, and among those who were, 49% did not know the new therapy usually is more successful than other treatments. Among people who were familiar with personalized medicine, 62% did not know drug costs would be significantly higher compared with other treatments.

Full Story:
HealthDay News
12/10/2018

The agreement would have allowed UK pharmaceutical regulations to remain under EMA authority after Brexit. Uncertainty around the planned withdrawal has caused worry in the life sciences sector.

Full Story:
MedCity News
12/10/2018

Officials at the Center for Vitreo-Retinal Diseases in Illinois discovered a ransomware attack on its servers Sept. 18 and have notified 20,371 patients whose data may have been compromised. Although there was no evidence that patient files were viewed, an investigation showed that an unauthorized user may have accessed the center's servers and could have viewed or accessed patients' names, health data, insurance information, addresses, dates of birth and phone numbers, as well as the Social Security numbers of some Medicare patients.

Full Story:
Health IT Security
More Summaries:
Medicare
12/10/2018

A ransomware attack against EMR hosting vendor IT Lighthouse on Sept. 19 could have compromised the information of 16,055 patients at Redwood Eye Center in California, including their names, medical treatment details, health insurance information, dates of birth and addresses. The eye center already notified the state attorney general about the potential data breach and has bolstered its security program and switched to a new vendor.

Full Story:
Health IT Security
12/10/2018

Memorial Hermann Health System received a 2018 HIMSS Davies Enterprise Award for reducing its rate of falls among older adult patients -- among the lowest rates in the US in 2016 -- by using a clinical decision support tool. The tool sends alerts that limit medication ordering for elderly patients, with its reliability and automation improved by the EHR's capacity to send dose range-checking alerts and add filters for conditions and age.

Full Story:
Healthcare IT News
12/10/2018

House lawmakers are expected to vote this week on bipartisan legislation that would permit the federal government to penalize pharmaceutical firms that misclassify drugs as generics to boost their profit from Medicaid, and Sen. Ron Wyden, D-Ore., one of the bill sponsors, said he hopes to see the measure become law by year's end. The measure is part of a legislative package that includes the ACE Kids Act, designed to improve care for children who have complex health needs.

Full Story:
The Hill
More Summaries:
Sen. Ron Wyden, Medicaid